TITLE

Successful treatment of gram-negative bacillary meningitis with moxalactam

AUTHOR(S)
Olson, David A.; Hoeprich, Paul D.; Nolan, Sheila M.; Goldstein, Elliot; Olson, D A; Hoeprich, P D; Nolan, S M; Goldstein, E
PUB. DATE
September 1981
SOURCE
Annals of Internal Medicine;Sep81, Vol. 95 Issue 3, p302
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Meningitis caused by enteric gram-negative bacilli is relatively uncommon but is very difficult to treat despite susceptibility in vitro to many antimicrobics. A major problem appears to be poor entry of many drugs into the central nervous system. Moxalactam is an investigational cephalosporin that attains concentrations in the cerebrospinal fluid that are 15% to 30% of contemporaneous serum concentrations; moreover, it is quite active against many of the enteric gram-negative bacilli. We used moxalactam to treat meningitis caused by Enterobacter cloacae, Klebsiella pneumoniae, and Escherichia coli in four adults and one child, giving up to 100 mg/kg body weight per day by intravenous injection. The concentrations of moxalactam in serum, lumbar, and ventricular cerebrospinal fluid exceeded the minimal lethal concentrations of all causative bacteria. The patients were cured. In this small series, moxalactam, when administered intravenously as the sole agent of therapy, was effective in the treatment of meningitis caused by susceptible gram-negative bacilli.
ACCESSION #
7078814

 

Related Articles

  • Cephalothin and cephaloridine therapy for bacterial meningitis. Fisher, Larry S.; Chow, Anthony W.; Yoshikawa, Thomas T.; Guze, Lucien B.; Fisher, L S; Chow, A W; Yoshikawa, T T; Guze, L B // Annals of Internal Medicine;May75, Vol. 82 Issue 5, p689 

    The efficacy of cephalothin and cephaloridine in the treatment of bacterial meningitis was evaluated from a review of 106 cases reported in the literature. Fifty-nine percent of 34 patients treated with intravenous cephalothin responded suboptimally; those receiving daily doses of 12 g or more...

  • Aseptic Meningitis Associated With Cephalosporins in an Infant With Trisomy 21. Nakajima, Wako; Ishida, Akira; Takahashi, Maya; Sato, Yoko; Ito, Tomoo; Takada, Goro // Journal of Child Neurology;Jun2007, Vol. 22 Issue 6, p780 

    The authors report a case of aseptic meningitis associated with cephalosporins in an infant. A 1 -year-old boy with trisomy 21 received several antimicrobials including cefotaxime and ceftriaxone for bacterial meningitis caused by Haemophilus influenzae b. High fever continued for more than a...

  • Community-acquired CTX-M-15-type ESBL-producing Escherichia coli meningitis: a case report and literature review. Elaldi, Nazif; Gozel, Mustafa G.; Kolayli, Fetiye; Engin, Aynur; Celik, Cem; Bakici, Mustafa Z.; Vahaboglu, Haluk // Journal of Infection in Developing Countries;May2013, Vol. 7 Issue 5, p424 

    In this report, a case of community-acquired acute bacterial meningitis (CA-ABM) caused by CTX-M-15-producing Escherichia coli in an elderly male patient was presented in the light of literature. Cultures of cerebrospinal fluid, blood, ear discharge, and stool samples yielded CTX-M-15-producing...

  • Pneumococcal meningitis. Davis, Sumari // South African Pharmaceutical Journal;2015, Vol. 82 Issue 5, p27 

    Streptococcus pneumoniae is one of the most common causes of bacterial meningitis, with high mortality and morbidity rates. Although some of the signs and symptoms of meningitis may be absent, virtually all patients present with at least one of the classic triad symptoms of a fever, neck...

  • Respiratory Viruses.  // Annals of Internal Medicine;2/17/2004, Vol. 140 Issue 4, p291 

    Presents an update on the session on Respiratory Viruses in the 2003 annual session of the American College of physicians. Ability of "Streptococcus pneumoniae" bacteria to develop resistance to antibacterial medications; Identification of pneumococcal resistance as an epidemic in children;...

  • Rational Use of Amikacin in Children. Arshad, Anila; Rehman, Sabahat; Zaka, Maryam; Mahmood, Khawaja Tahir // Journal of Pharmaceutical Sciences & Research;2011, Vol. 3 Issue 1, p995 

    Amikacin, an aminoglycoside, is used against Gram -ive and Gram +ive microorganisms for treating Sepsis, Meningitis, Jaundice neonatum, Respiratory diseases and Urinary Tract Infections. A retrospective study on Rational use of Amikacin in children was carried out to review the rationality of...

  • Pneumocephalus consequent to staphylococcal pneumonia and meningitis. Kumari, Anita; Agrawal, Satish C. // Journal of Pediatric Neurosciences;Jan-Jun2011, Vol. 6 Issue 1, p84 

    Pneumocephalus is a rare condition, characterized by the presence of gas in the cranial cavity, resulting from trauma, tumors and surgical or diagnostic procedures. Intracranial infection, without any predisposing factor like trauma or surgical intervention as a cause of pneumocephalus is...

  • Many common infections respond to cefprozil.  // Modern Medicine;Jul95, Vol. 63 Issue 7, p56 

    Presents an abstract of the article titled `Cefprozil, a new cephalosporin: Its use in various clinical trials,' by R.B. Gainer II originally published in the March 1995 issue of `South Medical Journal.'

  • Bug beater. Portyansky, Elena // Drug Topics;1/19/98, Vol. 142 Issue 2, p28 

    Presents information on the drug `Omnicef (cefdinir) which is the tenth third-generation cephalosporin in the United States. Indications carried by the extended-spectrum, semisynthetic oral cephalosporin which is manufactured by Warner-Lambert; Details on the availability of Omnicef.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics